42 studies found for:    HIV and pre exposure prophylaxis | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
2 Not yet recruiting Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Condition: HIV Infections
Interventions: Drug: Cabotegravir tablets;   Drug: TDF/FTC tablets;   Drug: TDF/FTC placebo tablets;   Drug: CAB placebo tablets;   Drug: CAB LA;   Drug: Placebo for CAB LA
3 Completed Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
4 Active, not recruiting Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents
Condition: HIV Infections
Intervention: Drug: Truvada
5 Active, not recruiting Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Rilpivirine;   Drug: Placebo
6 Completed The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
7 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
8 Completed Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
Condition: HIV Infections
Intervention: Drug: FTC 200 mg/TDF 300 mg fixed-dose combination tablet
9 Active, not recruiting Partners Demonstration Project of PrEP and ART
Condition: HIV Infection
Interventions: Drug: FTC-TDF PrEP;   Drug: ART
10 Completed Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention
Condition: Clinician Attitudes About PrEP.
Intervention:
11 Completed Factors Affecting PrEP Adherence
Condition: HIV Infection
Intervention: Drug: Emtricitabine/tenofovir disoproxil
12 Not yet recruiting Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
Condition: HIV
Intervention: Drug: Truvada
13 Recruiting PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Condition: HIV
Interventions: Drug: Truvada;   Device: Gel lubricant
14 Completed Self-Consent for PrEP Perspectives
Conditions: HIV;   PrEP
Intervention:
15 Completed Behavioral and Biomedical HIV Prevention Interventions for Thai Men Who Have Sex With Men
Condition: HIV Testing, MSM
Intervention:
16 Not yet recruiting Employing eSBI in HIV Testing Environments for At-risk Youth
Conditions: HIV;   Substance Use
Interventions: Behavioral: eSBI for Alcohol Use;   Behavioral: Nutrition Intervention for Health Promotion
17 Recruiting Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Condition: Human Immunodeficiency Virus
Interventions: Drug: emtricitabine/tenofovir;   Behavioral: CBT-based counseling
18 Recruiting Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots
Condition: PrEP Adherence Monitoring
Intervention: Drug: Truvada
19 Recruiting The Compartmental Biology of HIV in the Male Genital Tract
Conditions: Human Immunodeficiency Virus;   Virus Shedding
Intervention:
20 Active, not recruiting Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Behavioral: Sexual Health Counseling;   Behavioral: Enhanced Adherence Intervention;   Behavioral: PrEP Information (Active Control);   Behavioral: Standard of Care Adherence Support (Active Control)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years